CAS 232617-15-1

D-Ribose-L-cysteine(Mixture of Diastereomers)

CAS : 232617-15-1

Formule : C₈H₁₅NO₆S

Couleur et forme : Solid

Masse moléculaire : 253.2728

Ref: IN-DA002MP8

D-Ribose-L-cysteine

CAS : 232617-15-1

D-Ribose-L-cysteine is the antioxidant glutathione precursor.

Formule : C₈H₁₅NO₆S

Couleur et forme : Solid

Masse moléculaire : 253.27

Ref: TM-T24018

D-Ribose-L-cysteine(Mixture of Diastereomers)

Produit contrôlé

CAS : 232617-15-1

Stability Hygroscopic
Applications D-Ribose-L-cysteine is a prodrug of L-cysteine that has potential therapeutic advantage in the inhibition of astrocytoma cell proliferation (1,2). D-Ribose-L-cysteine has been shown to protect against acetaminophen-induced hepatic and renal toxicity.
References (1) Jurkowska, H. et al.: Amino Acids, 41, 131 (2011) (2) Slitt, A. et al.: Basic Clin. Pharm. Toxicol., 96, 487 (2005)

Formule : C₈H₁₅NO₆S

Couleur et forme : Neat

Masse moléculaire : 253.273

Ref: TR-R417550

D-Ribose-L-cysteine

CAS : 232617-15-1

D-Ribose-L-cysteine is a combination of D-ribose and L-cysteine. It is used for the treatment of bowel disease, radiation injury, pentobarbital sodium induced ileus, atherosclerotic lesion, oral hypoglycaemic, neuronal death, psychotic disorder in AIDS patients and active antiretroviral therapy. D-Ribose-L-cysteine has been shown to decrease ATP levels and increase histological damage in v79 cells. D-Ribose-L-cysteine has also been shown to have a protective effect on hamster V79 cells against inflammatory bowel disease by decreasing the release of inflammatory cytokines.

Formule : C₈H₁₅NO₆S

Degré de pureté : Min. 95%

Masse moléculaire : 253.28 g/mol

Ref: 3D-HJA61715